Trumenba is a vaccine that helps protect against meningococcal disease caused by Neisseria meningitidis serogroup B. This serious bacterial infection can lead to meningitis and septicemia, which can be life-threatening if not treated promptly. Trumenba works by stimulating the body’s immune system to produce antibodies that target the specific serogroup B strain of the bacteria.

As a medical professional, I highly recommend Trumenba for individuals at increased risk of meningococcal disease, such as adolescents and young adults, as well as those living in close quarters like college dormitories. The vaccine is administered in a series of two or three doses, depending on the age of the individual and their risk factors.

It is important to note that Trumenba may cause mild side effects such as pain at the injection site, redness or swelling, and mild fever. These symptoms typically resolve on their own within a few days and are a small price to pay for the protection that Trumenba provides against a potentially deadly disease.

I encourage my patients to discuss their risk factors for meningococcal disease with me so that we can determine if Trumenba is the right choice for them. By staying informed and taking proactive steps to protect against meningococcal disease, we can help ensure the health and well-being of our communities. If you have any questions or concerns about Trumenba or any other vaccines, please don’t hesitate to reach out to me.